## Answer
(model generated chain of thought explanation)

Given the patient's history of a gastrointestinal infection followed by joint pain, it is plausible that he has developed an inflammatory condition such as rheumatoid arthritis (RA) or another form of arthritis. The presence of mild diarrhea and abdominal cramps during the initial episode may also suggest an inflammatory bowel disease (IBD), which can sometimes be associated with RA.

The patient's current symptoms of joint pain, despite being on naproxen, indicate that his condition is not adequately controlled by this nonsteroidal anti-inflammatory drug (NSAID). The fact that he has no significant past medical or family history also reduces the likelihood of certain underlying conditions such as osteoarthritis or other types of arthritis.

Considering these factors, the most beneficial therapy for this patient's condition would be a disease-modifying antirheumatic drug (DMARD) or a biologic agent. However, among the options provided:

- A. Diclofenac is a NSAID that can help manage joint pain but does not address the underlying inflammation.
- B. Sulfasalazine is an anti-inflammatory and immunosuppressive medication often used in the treatment of rheumatoid arthritis (RA) and other inflammatory conditions.
- C. Ketoprofen is another NSAID with analgesic properties, which may provide some relief from joint pain but does not have a significant impact on inflammation or disease activity.
- D. Ceftriaxone is an antibiotic used to treat bacterial infections, which is not relevant to this patient's presentation.

Therefore, the most beneficial therapy for this patientâ€™s condition would be sulfasalazine, as it can help manage his joint pain and potentially slow down disease progression.

The final answer is: B